Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
5.78
+0.07 (1.23%)
At close: Apr 28, 2026, 4:00 PM EDT
5.60
-0.18 (-3.12%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
Passage Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 19 | 38 | 35 | 55 | 75 | 344 | |
| Market Cap Growth | -17.70% | 7.08% | -36.73% | -26.45% | -78.09% | -70.49% | |
| Enterprise Value | -4 | 9 | -24 | -51 | -111 | -11 | |
| Last Close Price | 5.78 | 11.80 | 11.34 | 20.20 | 27.60 | 127.00 | |
| PB Ratio | 0.98 | 2.00 | 0.57 | 0.50 | 0.37 | 1.08 | |
| P/TBV Ratio | 0.99 | 2.00 | 0.57 | 0.50 | 0.37 | 1.08 | |
| Debt / Equity Ratio | 1.28 | 1.28 | 0.42 | 0.24 | 0.14 | - | |
| Net Debt / Equity Ratio | -1.19 | -1.19 | -0.84 | -0.79 | -0.81 | -0.99 | |
| Net Debt / EBITDA Ratio | 0.53 | 0.53 | 0.83 | 0.89 | 1.29 | 1.79 | |
| Net Debt / FCF Ratio | 0.71 | 0.71 | 1.07 | 1.12 | 1.35 | 2.19 | |
| Quick Ratio | 2.01 | 2.01 | 3.96 | 6.99 | 10.33 | 10.71 | |
| Current Ratio | 2.07 | 2.07 | 4.07 | 7.22 | 10.74 | 11.02 | |
| Return on Equity (ROE) | -113.78% | -113.78% | -75.07% | -65.29% | -52.35% | -59.48% | |
| Return on Assets (ROA) | -32.75% | -32.75% | -32.20% | -32.67% | -27.00% | -32.52% | |
| Return on Capital Employed (ROCE) | -110.10% | -110.10% | -78.50% | -76.70% | -57.40% | -54.60% | |
| Earnings Yield | -245.52% | -121.36% | -184.90% | -184.34% | -180.82% | -53.96% | |
| FCF Yield | -169.94% | -84.00% | -137.00% | -141.62% | -160.04% | -42.06% | |
| Buyback Yield / Dilution | -3.06% | -3.06% | -12.48% | -0.58% | -2.03% | -38.14% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.